Dose Ranging Study in Elective Total Hip Replacement Surgery

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1,090

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Venous Thromboembolism
Interventions
DRUG

SR123781A

Trial Locations (14)

1642

Sanofi-Aventis, San Isidro

1715

Sanofi-Aventis, Sofia

34394

Sanofi-Aventis, Istanbul

70334

Sanofi-Aventis, Bucharest

101000

Sanofi-Aventis, Moscow

Unknown

Sanofi-Aventis, Providencia

Sanofi-Aventis, Bogotá

Sanofi-Aventis, Denmark

Sanofi-Aventis, Helsinki

Sanofi-Aventis, Oslo

Sanofi-Aventis, Warsaw

Sanofi-Aventis, Bromma

160 00

Sanofi-Aventis, Prague

04000

Sanofi-Aventis, México

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY